4-methoxy-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide;bis(N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide);4-methyl-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide
C94H80N12O9 — CID 158888472
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methoxy-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide;bis(N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide);4-methyl-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide
4-methoxy-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide;bis(N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide);4-methyl-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide (PubChem CID 158888472) has the molecular formula C94H80N12O9 and a molecular weight of 1521.75 g/mol. Its IUPAC name is 4-methoxy-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide;bis(N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide);4-methyl-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide.
Molecular Properties
| Compound Name | 4-methoxy-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide;bis(N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide);4-methyl-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide |
|---|---|
| PubChem CID | 158888472 |
| Molecular Formula | C94H80N12O9 |
| Molecular Weight | 1521.75 g/mol |
| Exact Mass | 1520.62 |
| IUPAC Name | 4-methoxy-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide;bis(N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide);4-methyl-N-[2-[2-(1-methylbenzimidazol-2-yl)acetyl]phenyl]benzamide |
| SMILES | COc1ccc(C(=O)Nc2ccccc2C(=O)Cc2nc3ccccc3n2C)cc1.Cc1ccc(C(=O)Nc2ccccc2C(=O)Cc2nc3ccccc3n2C)cc1.Cn1c(CC(=O)c2ccccc2NC(=O)c2ccccc2)nc2ccccc21.Cn1c(CC(=O)c2ccccc2NC(=O)c2ccccc2)nc2ccccc21 |
| InChI | InChI=1S/C24H21N3O3.C24H21N3O2.2C23H19N3O2/c1-27-21-10-6-5-9-20(21)25-23(27)15-22(28)18-7-3-4-8-19(18)26-24(29)16-11-13-17(30-2)14-12-16;1-16-11-13-17(14-12-16)24(29)26-19-8-4-3-7-18(19)22(28)15-23-25-20-9-5-6-10-21(20)27(23)2;2*1-26-20-14-8-7-13-19(20)24-22(26)15-21(27)17-11-5-6-12-18(17)25-23(28)16-9-3-2-4-10-16/h3-14H,15H2,1-2H3,(H,26,29);3-14H,15H2,1-2H3,(H,26,29);2*2-14H,15H2,1H3,(H,25,28) |
| InChIKey | JDXPQHUSGFXNPF-UHFFFAOYSA-N |
| XLogP | 17.32 |
| TPSA | 265.19 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 115 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1521.75 |
| LogP ≤ 5 | 17.32 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158888472 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.